TGRX-326 Pharmacokinetic Mass Balance

Clinical trial NCT06438367 · COMPLETED

Trial details

NCT number: NCT06438367
Sponsor: Shenzhen TargetRx Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2024-06-26
Primary completion: 2024-07-08
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.